sPLA2-V is markedly induced in adipocytes during obesity as a “metabolic sPLA2” and hydrolyzes PC in hyperlipidemic LDL to release OA and LA, which counteract adipose tissue inflammation and thereby ameliorate metabolic disorders [41]. The gene discussed is PLA2G2A; the disease is obesity disorder.